Quick Reference

Peptide Dosing Reference

Quick reference guide for peptide dosing. Search, filter, and find the information you need. Click any row for more details.

⚠️ For Research Purposes Only: This information is provided for educational purposes and reflects commonly reported practices in the research community. This is not medical advice, nor a recommendation to use any substance. Peptides discussed may not be FDA-approved for human use. Always consult a qualified healthcare provider.

Showing 16 of 16 peptides

🔥

Semaglutide

Weight Loss

FDA Approved

Commonly Reported

0.25mg - 2.4mg

Frequency

Once weekly

Route

Subcutaneous

Start low, titrate up over 16-20 weeks

GI side effects common during titration

View Full Details
🔥

Tirzepatide

Weight Loss

FDA Approved

Commonly Reported

2.5mg - 15mg

Frequency

Once weekly

Route

Subcutaneous

Start at 2.5mg, increase every 4 weeks

Similar GI profile to semaglutide

View Full Details
🔥

Retatrutide

Weight Loss

Phase 3 Trials

Commonly Reported

1mg - 12mg

Frequency

Once weekly

Route

Subcutaneous

Triple agonist - research compound

Not yet approved - research only

View Full Details
🔥

MOTS-c

Weight Loss

Research

Commonly Reported

5mg - 10mg

Frequency

Daily or 3-5x weekly

Route

Subcutaneous

Exercise mimetic peptide

Limited human data

View Full Details
💪

Ipamorelin

Muscle & Recovery

Research

Commonly Reported

200-300mcg

Frequency

2-3x daily

Route

Subcutaneous

Clean GH secretagogue, best before bed

May cause water retention

View Full Details
💪

CJC-1295 (no DAC)

Muscle & Recovery

Research

Commonly Reported

100mcg

Frequency

2-3x daily

Route

Subcutaneous

Often stacked with Ipamorelin

DAC version has longer half-life

View Full Details
💪

CJC-1295 (with DAC)

Muscle & Recovery

Research

Commonly Reported

2mg

Frequency

1-2x weekly

Route

Subcutaneous

Extended release version

Can cause GH bleed, harder to time

View Full Details
💪

Kisspeptin

Muscle & Recovery

Research

Commonly Reported

Variable

Frequency

Multiple daily

Route

Subcutaneous/IV

Hormone regulation, short half-life

Experimental protocols only

View Full Details
🩹

BPC-157

Healing

Research

Commonly Reported

250-500mcg

Frequency

1-2x daily

Route

Subcutaneous/Oral

Inject near injury site or systemic

May promote angiogenesis - caution with cancer

View Full Details
🩹

TB-500

Healing

Research

Commonly Reported

2-2.5mg

Frequency

2x weekly (loading), 1x weekly (maintenance)

Route

Subcutaneous

Systemic healing, stacks well with BPC-157

Same angiogenesis concerns as BPC

View Full Details
🩹

GHK-Cu

Healing

Cosmetic/Research

Commonly Reported

1-2mg (injectable) or 1-2% (topical)

Frequency

Daily

Route

Topical/Subcutaneous

Most common as topical for skin

Avoid with copper sensitivity

View Full Details

Epithalon

Skin & Anti-Aging

Research

Commonly Reported

5-10mg

Frequency

Daily for 10-20 days

Route

Subcutaneous

Cycled 2-3x per year

Telomerase activation - theoretical cancer concern

View Full Details
🧠

Semax

Cognitive

Approved (Russia)

Commonly Reported

200-600mcg

Frequency

1-2x daily

Route

Nasal spray

Cycle 2-3 weeks on/off

May cause nasal irritation

View Full Details
🧠

Selank

Cognitive

Approved (Russia)

Commonly Reported

250-500mcg

Frequency

1-3x daily

Route

Nasal spray

Anxiolytic + cognitive boost

May be too sedating for some

View Full Details
🛡️

Thymosin Alpha-1

Immune

Approved (35+ countries)

Commonly Reported

1.6mg

Frequency

Daily or every other day

Route

Subcutaneous

Immune modulator

May worsen autoimmune conditions

View Full Details
💜

PT-141 (Bremelanotide)

Immune

FDA Approved

Commonly Reported

1.75mg

Frequency

As needed (max 8x/month)

Route

Subcutaneous

Take 45min before activity

Nausea very common (40%), BP increase

View Full Details

Need to calculate your dose?

Use our reconstitution calculator to figure out exactly how much to draw.

Open Calculator →

⚠️ For Research Purposes Only

This dosing reference is for educational purposes only and reflects commonly reported practices in the research community. This is not a recommendation for any specific dose. Peptides discussed may not be FDA-approved for human use. Always consult a qualified healthcare provider. PepGains does not sell peptides or provide medical advice.